Anika Therapeutics, Inc. Sales Revenue, Services, Net (Deprecated 2018-01-31)
Anika Therapeutics, Inc. (ANIK) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $5.64 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2018-02-27
- Anika Therapeutics, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $504.00K, a 17.21% increase year-over-year.
- Anika Therapeutics, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $6.00K, a 0.00% change year-over-year.
- Anika Therapeutics, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $5.12M, a 85266.67% increase year-over-year.
- Anika Therapeutics, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $5.00K, a 0.00% change year-over-year.
- Anika Therapeutics, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2017 was $5.64M, a 1161.07% increase from fiscal 2016.
- Anika Therapeutics, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2016 was $447.00K, a 91.57% decline from fiscal 2015.
- Anika Therapeutics, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2015 was $5.30M, a 82.39% decline from fiscal 2014.
- Anika Therapeutics, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2014 was $30.12M, a 810.83% increase from fiscal 2013.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $504.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $510.00K derived: sum of 2 quarters · filed 2018-02-27 | $5.63M derived: sum of 3 quarters · filed 2018-02-27 | $5.64M 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $6.00K 10-Q · filed 2017-10-27 | $5.13M derived: sum of 2 quarters · filed 2017-10-27 | $5.13M 10-Q · filed 2017-10-27 | $5.56M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-06-30 | $5.12M 10-Q · filed 2017-07-28 | $5.13M 10-Q · filed 2017-07-28 | $5.56M derived: sum of 3 quarters · filed 2018-02-27 | $5.56M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-03-31 | $5.00K 10-Q · filed 2017-05-04 | $435.00K derived: sum of 2 quarters · filed 2018-02-27 | $441.00K derived: sum of 3 quarters · filed 2018-02-27 | $447.00K derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-12-31 | $430.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $436.00K derived: sum of 2 quarters · filed 2018-02-27 | $442.00K derived: sum of 3 quarters · filed 2018-02-27 | $447.00K 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $6.00K 10-Q · filed 2017-10-27 | $12.00K derived: sum of 2 quarters · filed 2017-10-27 | $17.00K 10-Q · filed 2017-10-27 | $5.30M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $6.00K 10-Q · filed 2017-07-28 | $11.00K 10-Q · filed 2017-07-28 | $5.30M derived: sum of 3 quarters · filed 2018-02-27 | $5.30M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $5.00K 10-Q · filed 2017-05-04 | $5.29M derived: sum of 2 quarters · filed 2018-02-27 | $5.30M derived: sum of 3 quarters · filed 2018-02-27 | $5.30M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $5.29M derived: sum of 2 quarters · filed 2018-02-27 | $5.30M derived: sum of 3 quarters · filed 2018-02-27 | $5.30M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $5.00K 10-Q · filed 2016-11-01 | $5.56K 10-Q · filed 2015-11-03 | $11.00K derived: sum of 2 quarters · filed 2016-11-01 | $16.00K 10-Q · filed 2016-11-01 | $16.73K 10-Q · filed 2015-11-03 | $5.39M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-06-30 | $6.00K 10-Q · filed 2016-08-01 | $5.53K 10-Q · filed 2015-08-04 | $11.00K 10-Q · filed 2016-08-01 | $11.17K 10-Q · filed 2015-08-04 | $5.39M derived: sum of 3 quarters · filed 2017-02-24 | $5.47M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-03-31 | $5.00K 10-Q · filed 2016-05-03 | $5.64K 10-Q · filed 2015-05-04 | $5.38M derived: sum of 2 quarters · filed 2017-02-24 | $5.46M derived: sum of 3 quarters · filed 2017-02-24 | $10.47M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $5.45M derived: sum of 2 quarters · filed 2017-02-24 | $10.46M derived: sum of 3 quarters · filed 2017-02-24 | $30.12M 10-K · filed 2017-02-24 | $30.12M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $80.11K 10-Q · filed 2015-11-03 | $5.09M derived: sum of 2 quarters · filed 2015-11-03 | $24.75M 10-Q · filed 2015-11-03 | $25.81M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $5.01M 10-Q · filed 2015-08-04 | $24.67M 10-Q · filed 2015-08-04 | $25.73M derived: sum of 3 quarters · filed 2016-03-10 | $26.46M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $19.66M 10-Q · filed 2015-05-04 | $20.72M derived: sum of 2 quarters · filed 2016-03-10 | $21.45M derived: sum of 3 quarters · filed 2016-03-10 | $22.21M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $1.79M derived: sum of 2 quarters · filed 2016-03-10 | $2.55M derived: sum of 3 quarters · filed 2016-03-10 | $3.31M 10-K · filed 2016-03-10 | $3.31M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $731.09K 10-Q · filed 2014-11-06 | $1.49M derived: sum of 2 quarters · filed 2014-11-06 | $2.24M 10-Q · filed 2014-11-06 | $3.39M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $760.97K 10-Q · filed 2014-08-04 | $1.51M 10-Q · filed 2014-08-04 | $2.66M derived: sum of 3 quarters · filed 2015-03-13 | $3.37M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $752.52K 10-Q · filed 2014-05-05 | $1.90M derived: sum of 2 quarters · filed 2015-03-13 | $2.61M derived: sum of 3 quarters · filed 2015-03-13 | $3.35M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.86M derived: sum of 2 quarters · filed 2015-03-13 | $2.60M derived: sum of 3 quarters · filed 2015-03-13 | $3.35M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $711.17K 10-Q · filed 2013-11-05 | $1.45M derived: sum of 2 quarters · filed 2013-11-05 | $2.20M 10-Q · filed 2013-11-05 | $2.92M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $742.49K 10-Q · filed 2013-08-06 | $1.49M 10-Q · filed 2013-08-06 | $2.21M derived: sum of 3 quarters · filed 2014-03-13 | $2.91M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $747.33K 10-Q · filed 2013-05-06 | $1.47M derived: sum of 2 quarters · filed 2014-03-13 | $2.17M derived: sum of 3 quarters · filed 2014-03-13 | $2.89M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $718.74K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $1.42M derived: sum of 2 quarters · filed 2014-03-13 | $2.14M derived: sum of 3 quarters · filed 2014-03-13 | $2.82M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $699.82K 10-Q · filed 2012-11-08 | $1.43M derived: sum of 2 quarters · filed 2012-11-08 | $2.10M 10-Q · filed 2012-11-08 | $2.63M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $726.17K 10-Q · filed 2012-08-07 | $1.40M 10-Q · filed 2012-08-07 | $1.93M derived: sum of 3 quarters · filed 2013-03-14 | $2.62M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $677.52K 10-Q · filed 2012-05-07 | $1.21M derived: sum of 2 quarters · filed 2013-03-14 | $1.90M derived: sum of 3 quarters · filed 2013-03-14 | $2.67M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $528.14K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $1.22M derived: sum of 2 quarters · filed 2013-03-14 | $2.00M derived: sum of 3 quarters · filed 2013-03-14 | $2.82M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $689.82K 10-Q · filed 2011-11-04 | $1.47M derived: sum of 2 quarters · filed 2011-11-04 | $2.29M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $778.87K 10-Q/A · filed 2011-08-10 | $1.60M 10-Q/A · filed 2011-08-10 | ||||||
| 2009-12-31 | $2.81M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |